Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma

Condition:   Asthma Interventions:   Drug: Placebo;   Drug: Umeclidinium;   Drug: Fluticasone Furoate;   Drug: Albuterol/salbutamol Sponsor:   GlaxoSmithKline Not yet recruiting - verified January 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials